National Health Valuation
| WX6 Stock | EUR 66.00 1.00 1.49% |
At this time, the firm appears to be overvalued. National Health Investors secures a last-minute Real Value of €62.56 per share. The latest price of the firm is €66.0. Our model forecasts the value of National Health Investors from analyzing the firm fundamentals such as Return On Equity of 0.0467, profit margin of 0.24 %, and Current Valuation of 3.32 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that National Health's price fluctuation is very steady at this time. Calculation of the real value of National Health Investors is based on 3 months time horizon. Increasing National Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the National stock is determined by what a typical buyer is willing to pay for full or partial control of National Health Investors. Since National Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of National Stock. However, National Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 66.0 | Real 62.56 | Hype 67.0 | Naive 67.99 |
The real value of National Stock, also known as its intrinsic value, is the underlying worth of National Health Investors Company, which is reflected in its stock price. It is based on National Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of National Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of National Health Investors helps investors to forecast how National stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of National Health more accurately as focusing exclusively on National Health's fundamentals will not take into account other important factors: National Health Total Value Analysis
National Health Investors is at this time estimated to have takeover price of 3.32 B with market capitalization of 2.28 B, debt of 1.15 B, and cash on hands of 5.74 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the National Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.32 B | 2.28 B | 1.15 B | 5.74 M |
National Health Investor Information
About 63.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.86. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. National Health Investors last dividend was issued on the 30th of March 2023. National Health Investors is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.National Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. National Health has an asset utilization ratio of 11.09 percent. This implies that the Company is making €0.11 for each dollar of assets. An increasing asset utilization means that National Health Investors is more efficient with each dollar of assets it utilizes for everyday operations.National Health Ownership Allocation
National Health Investors maintains a total of 43.39 Million outstanding shares. Over half of National Health's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in National Health Investors. Please watch out for any change in the institutional holdings of National Health Investors as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.National Health Profitability Analysis
The company reported the revenue of 278.19 M. Net Income was 66.4 M with profit before overhead, payroll, taxes, and interest of 268.98 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates National Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in National Health and how it compares across the competition.
About National Health Valuation
The stock valuation mechanism determines National Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of National Health. We calculate exposure to National Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of National Health's related companies.is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHIs portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. NATL HEALTH operates under REIT - Healthcare Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 16 people.
8 Steps to conduct National Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates National Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct National Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain National Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine National Health's revenue streams: Identify National Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research National Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish National Health's growth potential: Evaluate National Health's management, business model, and growth potential.
- Determine National Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate National Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets |